Preview

Parodontologiya

Advanced search

Management of drug-induced gingival overgrowth associated with calcium channel blocker therapy using a diode laser: a clinical case report

https://doi.org/10.33925/1683-3759-2025-1016

Abstract

Relevance. Drug-induced gingival overgrowth (DIGO) is a recognized adverse effect of various medications, often leading to significant impairments in dental aesthetics, phonetics, mastication, and oral hygiene.

Clinical case description. This report describes a clinical case of drug-induced gingival overgrowth (DIGO) associated with calcium channel blocker therapy. Initial non-surgical periodontal therapy, consultation with the patient’s physician, and diode laser-assisted gingival contouring, along with strong patient adherence, led to stable clinical outcomes over a one-year follow-up period with minimal risk of recurrence.

Conclusion. This clinical case demonstrates the efficacy of diode laser treatment in managing similar conditions and emphasizes the importance of an interdisciplinary approach in the comprehensive care of patients with druginduced gingival overgrowth.

About the Author

O. V. Abramov
Dental clinic Siti kit
Russian Federation

Oleg V. Abramov, DMD

159 Kirov Str., Chelyabinsk, Russian Federation, 454000



References

1. Corrêa JD, Queiroz-Junior CM, Costa JE, Teixeira AL, Silva TA. Phenytoin-induced gingival overgrowth: a review of the molecular, immune, and inflammatory features. ISRN Dent. 2011;2011:497850. doi: 10.5402/2011/497850

2. Ramírez-Rámiz A, Brunet-LLobet L, Lahor-Soler E, Miranda-Rius J. On the Cellular and Molecular Mechanisms of Drug-Induced Gingival Overgrowth. The Open Dentistry Journal. 2017;11(1):420. doi: 10.2174/1874210601711010420

3. Parwani R, Parwani SR. Management of phenytoininduced gingival enlargement: a case report. General Dentistry. 2013;61(6):61-67. Available from: https://www.researchgate.net/publication/257070771_Management_of_phenytoin-induced_gingival_enlargement_A_case_report

4. Bharti V, Bansal C. Drug-induced gingival overgrowth: The nemesis of gingiva unravelled. J Indian Soc Periodontol. 2013;17(2):182-187. doi: 10.4103/0972-124X.113066

5. Orehova LYu, Osipova MV. The role of periodontologist in diagnostics of the internal pathology. Parodontologiya. 2010;15(4):20-25 (In Russ.). Available from: https://elibrary.ru/item.asp?edn=okckun

6. Trackman PC, Kantarci A. Molecular and Clinical Aspects of Drug-induced Gingival Overgrowth. Journal of Dental Research. 2015;94(4):540-546. doi: 10.1177/0022034515571265

7. Ellis JS, Seymour RA, Steele JG, Robertson P, Butler TJ, Thomason JM. Prevalence of Gingival Overgrowth Induced by Calcium Channel Blockers: A CommunityBased Study. Journal of Periodontology. 1999;70(1):63–7. doi: 10.1902/jop.1999.70.1.63

8. Droździk A, Droździk M. Drug-Induced Gingival Overgrowth—Molecular Aspects of Drug Actions. International Journal of Molecular Sciences. 2023;24(6):5448. doi: 10.3390/ijms24065448

9. Taylor BA. Management of drug-induced gingival enlargement. Australian Prescriber. 2003;26(1). doi: 10.18773/austprescr.2003.007

10. Hallmon WW, Rossmann JA. The role of drugs in the pathogenesis of gingival overgrowth. A collective review of current concepts. Periodontology 2000. 1999;21(1):176–196. doi: 10.1111/j.1600-0757.1999.tb00175.x

11. Atrushkevich VG, Pudovkina EA. Nonsurgical management of the gingival оvergrowth which are constantly receiving calcium channel blockers. Clinical case. Parodontologiya. 2015; 20(3):46-50 (In Russ.). Available from: https://elibrary.ru/unfajr

12. Mavrogiannis M, Ellis JS, Thomason JM, Seymour RA. The management of drug-induced gingival overgrowth. Journal of Clinical Periodontology. 2006;33(6):434–439 doi: 10.1111/j.1600-051X.2006.00930.x

13. Mandra YuV, Zhegalina NM, Svetlakova EN, Nersesyan PM. Experience of using dynamic electroneurostimulation after laser gingivectomy. Medical science and education of Ural. 2015;16(3):38-41 (In Russ.). Available from: https://elibrary.ru/umeypj

14. Sabarudin MA, Beh YH, Hassan A, Ghani ZA, Taib H. Surgical Intervention on Drug-Influenced Gingival Enlargement using Diode Laser Therapy. Malaysian Journal of Science Health & Technology. 2022;8:8–12. doi: 10.33102/mjosht.v8i.285

15. Maboudi A, Fekrazad R, Shiva A, Salehabadi N, Moosazadeh M, Ehsani H, et al. Gingivectomy with Diode Laser Versus the Conventional Scalpel Surgery and Nonsurgical Periodontal Therapy in Treatment of Orthodontic Treatment-Induced Gingival Enlargement: A Systematic Review. Photobiomodulation, Photomedicine, and Laser Surgery. 2023;41(9):449–459. doi: 10.1089/photob.2023.0060

16. Kohale BR, Agrawal AA, Raut CP. Effect of lowlevel laser therapy on wound healing and patients’ response after scalpel gingivectomy: A randomized clinical split-mouth study. Journal Indian Society of Periodontology. 2018;22(5):419. doi: 10.4103/jisp.jisp_239_18

17. Tiunova NV, Tolmacheva SM, Vdovina LV, Ivanchenko EYu. Tactics of patient management with gingival hypertrophy on the background of antihypertensive drugs treatment. Dental Forum. 2021;(4):74-75 (In Russ.). Available from: https://elibrary.ru/turrvn


Supplementary files

Review

For citations:


Abramov OV. Management of drug-induced gingival overgrowth associated with calcium channel blocker therapy using a diode laser: a clinical case report. Parodontologiya. 2025;30(1):94-102. (In Russ.) https://doi.org/10.33925/1683-3759-2025-1016

Views: 207


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1683-3759 (Print)
ISSN 1726-7269 (Online)